• RSL3 and the New Frontier of Cancer Cell Death: Mechanist...

  2025-09-30

  This thought-leadership article explores the transformative potential of RSL3, a selective glutathione peroxidase 4 inhibitor, in redefining cancer research through the lens of ferroptosis. We synthesize mechanistic insights, recent evidence, and strategic guidance to empower translational researchers to leverage ferroptosis induction, synthetic lethality, and redox modulation in oncology.

• DRB (HIV Transcription Inhibitor): Unveiling Translationa...

  2025-09-29

  Explore the unique molecular mechanisms of 5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole (DRB), a potent transcriptional elongation inhibitor and CDK pathway modulator. This article offers novel insights into translational control, cell fate, and antiviral applications, expanding beyond conventional HIV research.

• DRB (HIV Transcription Inhibitor): Dissecting Transcripti...

  2025-09-28

  Delve into the scientific intricacies of 5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole (DRB), a potent transcriptional elongation and CDK inhibitor. This article uniquely explores DRB’s mechanistic impact on RNA polymerase II, its intersection with liquid-liquid phase separation, and advanced applications in cell fate engineering and disease modeling.

• RSL3 and the Redox-Apoptotic Axis: Next-Gen Strategies in...

  2025-09-27

  Explore how RSL3, a potent glutathione peroxidase 4 inhibitor, uniquely modulates oxidative stress and ferroptosis in cancer biology. This article unveils the intersection between ROS-mediated non-apoptotic cell death and emerging apoptotic signaling, offering novel insight beyond traditional ferroptosis research.

• RSL3 as a Precision GPX4 Inhibitor: Unraveling Ferroptosi...

  2025-09-26

  Explore how RSL3, a potent glutathione peroxidase 4 inhibitor, enables advanced dissection of the ferroptosis signaling pathway in cancer biology. This article uniquely integrates emerging mechanistic insights and highlights RSL3’s translational value for targeting redox vulnerabilities in oncogenic RAS-driven tumors.

• S63845: Advancing MCL1 Inhibition for Precision Apoptosis...

  2025-09-25

  Discover how S63845, a leading MCL1 inhibitor, unlocks new frontiers in hematological cancer research by enabling highly selective mitochondrial apoptotic pathway activation. This deep dive explores advanced mechanistic insights, emerging combinatorial strategies, and practical guidance for leveraging S63845 beyond existing protocols.

• Triptolide: Unveiling Its Dual Role in Pluripotency and D...

  2025-09-24

  Explore how Triptolide, a potent IL-2/MMP-3/MMP7/MMP19 inhibitor, provides unique insights into both embryonic pluripotency and disease mechanisms. This in-depth article offers a fresh perspective by bridging developmental biology with cancer and rheumatoid arthritis research using Triptolide.

• Cell Counting Kit-8 (CCK-8): Advancing Quantitative Cell ...

  2025-09-23

  Explore the use of Cell Counting Kit-8 (CCK-8) in high-precision cell viability measurement, with a focus on its application in tissue engineering, cancer research, and metabolic studies. This article delves into CCK-8's scientific mechanism, practical implementation, and its role in evaluating cellular responses within advanced biomaterial scaffolds.

• The PAS domains of AHR consist of two

  2025-03-03

  

  The PAS domains of AHR consist of two regions, PAS-A and PAS-B, which function as interfaces for dimerization with ARNT and for ligand binding, respectively [14]. Although both the bHLH and the PAS-A domains have been shown to be involved in dimerization with ARNT, a recent report suggests that only

• Notably AR and AR signaling can also occur

  2025-03-03

  

  Notably, β2AR and β3AR signaling can also occur via mechanisms independent from G protein [13]. Additionally, the response to GPCR stimulus can be modified by various parameters, including chronic stimulation, cell hypoxia, acidosis, and aging [14], [15], [16]. GRKs have a significant role in the r

• AdK as an important upstream

  2025-03-03

  

  AdK as an important upstream regulator of adenosine-based homeostasis represents a promising drug target since it leads to an increase in adenosine concentrations. Taking into account that the adenosine formation is only increased in affected tissues under stress with high adenosine levels, AdK inhi

• Tension within the network could

  2025-03-03

  

  Tension within the network could be explained by two potential mechanisms: the more classical contractility that is dependent on motor proteins that are pulling Gentiana macrophylla extract filaments towards each other [10]; or contractility that is caused by disassembly of a crosslinked network of

• Although the mechanisms of APP secretion are well

  2025-03-03

  

  Although the mechanisms of APP secretion are well characterised (for review see Ref. [1]), production of soluble AChE species is less well understood although we have reported that a metalloproteinase can shed AChE similarly to APP [16], [17]. Recently it has also been demonstrated that cellular pre

• Protein homeostasis disruption Introduction The lysosomal st

  2025-03-03

  

  Introduction The lysosomal storage disorder Gaucher disease (Mendelian Inheritance in Man, OMIM #230800) results from the recessively inherited deficiency of lysosomal glucocerebrosidase (GCase, EC 3.2.1.45), caused by mutations in the gene GBA1 (MIM# 606463) located on chromosome 1q21. The enzymat

• br LOX in esophageal cancer Various studies suggest

  2025-03-03

  

  5-LOX in esophageal cancer Various studies suggest that abnormal levels of AA metabolites play an essential role in human esophageal adenocarcinogenesis (EAC). The key AA derivatives of 5-LOX signaling molecules namely include, 5-HETE, LTB4, and cysteinyl LTs, which are well-known to initiate inf

15336 records 2/1023 page Previous Next 12345 下5页 Last page